Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 22, 1332-1335, December 1, 1962]
© 1962 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Strozier, V. N.
Right arrow Articles by Nyhan, W. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Strozier, V. N.
Right arrow Articles by Nyhan, W. L.

Effects of Cytoxan on the Proteins of Sensitive and Resistant Strains of the L1210 Leukemia*

V. Nelle Strozier{dagger} and William L. Nyhan{ddagger}

( Department of Pediatrics, The Johns Hopkins University, School of Medicine, Baltimore, Maryland)

Carcinostatic doses of Cytoxan were administered to two groups of mice: one bearing a sensitive form of the L1210 leukemia, the other a resistant form. The incorporation of methionine-S35 into protein was investigated in each of these two groups and in untreated controls. In the resistant tumor there was no significant decrease in methionine incorporation following therapy. In the sensitive tumor there was a marked decrease, which was greatest in the nuclear fractions. No effect of Cytoxan was seen in the livers of any of the animals.

These data indicate that the inhibition observed in the formation of tumor proteins following the administration of alkylating agents is related to the biologic action of these compounds and may be directly related to the mechanism of their activity.

* Aided by grants from The American Cancer Society, The Leukemia Society, and The U.S. Public Health Service (C-4493).

{dagger} Fellow in Pediatric Research (Training Grant 2A-5275).

{ddagger} Faculty Research Associate of The American Cancer Society.

Received 7/ 7/62.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1962 by the American Association for Cancer Research.